Literature DB >> 24611595

Ion fusion of high-resolution LC-MS-based metabolomics data to discover more reliable biomarkers.

Zhongda Zeng1, Xinyu Liu, Weidong Dai, Peiyuan Yin, Lina Zhou, Qiang Huang, Xiaohui Lin, Guowang Xu.   

Abstract

A systematic approach for the fusion of associated ions from a common molecule was developed to generate "one feature for one peak" metabolomics data. This approach guarantees that each molecule is equally selected as a potential biomarker and may largely enhance the chance to obtain reliable findings without employing redundant ion information. The ion fusion is based on low mass variation in contrast to the theoretical calculation measured by a high-resolution mass spectrometer, such as LTQ orbitrap, and a high correlation of ion pairs from the same molecule. The mass characteristics of isotopic distribution, neutral loss, and adduct ions were simultaneously applied to inspect each extracted ion in the range of a predefined retention time window. The correlation coefficient was computed with the corresponding intensities of each ion pair among all experimental samples. Serum metabolomics data for the investigation of hepatocellular carcinoma (HCC) and healthy controls were utilized as an example to demonstrate this strategy. In total, 609 and 1084 ion pairs were respectively found meeting one or more criteria for fusion, and therefore fused to 106 and 169 metabolite features of the datasets in the positive and negative modes, respectively. The important metabolite features were separately discovered and compared to distinguish the HCC from the healthy controls using the two datasets with and without ion fusion. The results show that the developed method can be an effective tool to process high-resolution mass spectrometry data in "omics" studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24611595     DOI: 10.1021/ac500878x

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  8 in total

1.  Two complementary reversed-phase separations for comprehensive coverage of the semipolar and nonpolar metabolome.

Authors:  Fuad J Naser; Nathaniel G Mahieu; Lingjue Wang; Jonathan L Spalding; Stephen L Johnson; Gary J Patti
Journal:  Anal Bioanal Chem       Date:  2017-12-18       Impact factor: 4.142

2.  Mass Spectral Feature List Optimizer (MS-FLO): A Tool To Minimize False Positive Peak Reports in Untargeted Liquid Chromatography-Mass Spectroscopy (LC-MS) Data Processing.

Authors:  Brian C DeFelice; Sajjan Singh Mehta; Stephanie Samra; Tomáš Čajka; Benjamin Wancewicz; Johannes F Fahrmann; Oliver Fiehn
Journal:  Anal Chem       Date:  2017-03-06       Impact factor: 6.986

Review 3.  Trends in the application of high-resolution mass spectrometry for human biomonitoring: An analytical primer to studying the environmental chemical space of the human exposome.

Authors:  Syam S Andra; Christine Austin; Dhavalkumar Patel; Georgia Dolios; Mahmoud Awawda; Manish Arora
Journal:  Environ Int       Date:  2017-01-04       Impact factor: 9.621

Review 4.  Applications of Fourier Transform Ion Cyclotron Resonance (FT-ICR) and Orbitrap Based High Resolution Mass Spectrometry in Metabolomics and Lipidomics.

Authors:  Manoj Ghaste; Robert Mistrik; Vladimir Shulaev
Journal:  Int J Mol Sci       Date:  2016-05-25       Impact factor: 5.923

5.  CliqueMS: a computational tool for annotating in-source metabolite ions from LC-MS untargeted metabolomics data based on a coelution similarity network.

Authors:  Oriol Senan; Antoni Aguilar-Mogas; Miriam Navarro; Jordi Capellades; Luke Noon; Deborah Burks; Oscar Yanes; Roger Guimerà; Marta Sales-Pardo
Journal:  Bioinformatics       Date:  2019-10-15       Impact factor: 6.937

6.  Reproducible untargeted metabolomics workflow for exhaustive MS2 data acquisition of MS1 features.

Authors:  Miao Yu; Georgia Dolios; Lauren Petrick
Journal:  J Cheminform       Date:  2022-02-16       Impact factor: 5.514

Review 7.  Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation.

Authors:  Wei Guo; Hor Yue Tan; Ning Wang; Xuanbin Wang; Yibin Feng
Journal:  Cancer Manag Res       Date:  2018-04-11       Impact factor: 3.989

8.  Metabolomic Assessment of Acute Cholestatic Injuries Induced by Thioacetamide and by Bile Duct Ligation, and the Protective Effects of Huang-Lian-Jie-Du-Decoction.

Authors:  Dan-Dan Wei; Jun-Song Wang; Jin-Ao Duan; Ling-Yi Kong
Journal:  Front Pharmacol       Date:  2018-05-08       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.